Linxiao Wang

752 total citations
46 papers, 593 citations indexed

About

Linxiao Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Organic Chemistry. According to data from OpenAlex, Linxiao Wang has authored 46 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Organic Chemistry. Recurrent topics in Linxiao Wang's work include Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Cancer therapeutics and mechanisms (7 papers). Linxiao Wang is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers) and Cancer therapeutics and mechanisms (7 papers). Linxiao Wang collaborates with scholars based in China, United States and New Zealand. Linxiao Wang's co-authors include Pengwu Zheng, Wufu Zhu, Qidong Tang, Shan Xu, Xianju Zhou, Ning‐Hua Tan, Yongli Duan, Ping Gong, Yongrong Yao and Wufu Zhu and has published in prestigious journals such as Chemical Engineering Journal, Journal of Neurochemistry and Cellular and Molecular Life Sciences.

In The Last Decade

Linxiao Wang

41 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linxiao Wang China 18 248 198 79 74 61 46 593
Davide Colavito Italy 16 201 0.8× 154 0.8× 41 0.5× 56 0.8× 14 0.2× 43 830
Lihui Wang China 14 308 1.2× 44 0.2× 48 0.6× 90 1.2× 122 2.0× 32 864
Sihan Li United States 13 329 1.3× 21 0.1× 71 0.9× 27 0.4× 33 0.5× 25 631
Wang Wang China 16 200 0.8× 178 0.9× 32 0.4× 10 0.1× 68 1.1× 44 660
Wen Ma China 18 277 1.1× 26 0.1× 23 0.3× 29 0.4× 88 1.4× 56 793
Junjing Zhang China 12 272 1.1× 16 0.1× 38 0.5× 62 0.8× 87 1.4× 32 703
Alan D. Robertson United Kingdom 17 405 1.6× 205 1.0× 12 0.2× 57 0.8× 15 0.2× 31 887
Henri Mattes Switzerland 17 507 2.0× 247 1.2× 47 0.6× 61 0.8× 15 0.2× 29 915
Wenping Li United States 11 246 1.0× 191 1.0× 14 0.2× 11 0.1× 23 0.4× 44 796
Yoshinori Takei Japan 17 564 2.3× 58 0.3× 41 0.5× 28 0.4× 16 0.3× 50 878

Countries citing papers authored by Linxiao Wang

Since Specialization
Citations

This map shows the geographic impact of Linxiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linxiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linxiao Wang more than expected).

Fields of papers citing papers by Linxiao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linxiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linxiao Wang. The network helps show where Linxiao Wang may publish in the future.

Co-authorship network of co-authors of Linxiao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Linxiao Wang. A scholar is included among the top collaborators of Linxiao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linxiao Wang. Linxiao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Meng, Jiangang Xie, Linxiao Wang, et al.. (2025). TNF-α in traumatic brain injury: a bidirectional effect in regulating neuroimmune and inflammatory responses. Cellular and Molecular Life Sciences. 82(1). 372–372.
2.
Guo, Qiuyan, Shan Xu, Dan Qiao, et al.. (2024). Space-confined nanozyme with cascade reaction based on PCN-224 for synergistic bacterial infection treatment and NIR fluorescence imaging of wound bacterial infections. Chemical Engineering Journal. 487. 150642–150642. 21 indexed citations
3.
Wang, Linxiao, et al.. (2024). Comparative analysis of models in predicting the effects of SNPs on TF-DNA binding using large-scale in vitro and in vivo data. Briefings in Bioinformatics. 25(2). 1 indexed citations
6.
Wang, Linxiao, et al.. (2024). T6496 targeting EGFR mediated by T790M or C797S mutant: machine learning, virtual screening and bioactivity evaluation study. Journal of Biomolecular Structure and Dynamics. 43(6). 3144–3155. 2 indexed citations
7.
Yang, Yang, Mengting Yu, Li Fu, et al.. (2023). Based on virtual screening methods and biological activity assessment, AK-968/13030056 has been identified as a potential mTOR inhibitor. Journal of Molecular Structure. 1302. 137425–137425. 4 indexed citations
8.
Xie, Zhouling, Jiaojiao Guo, Yan Li, et al.. (2023). T5S1607 identified as a antibacterial FtsZ inhibitor:Virtual screening combined with bioactivity evaluation for the drug discovery. Computational Biology and Chemistry. 108. 108006–108006. 4 indexed citations
9.
Zhang, Jianqing, Han Zhang, Sheng Tang, et al.. (2023). Design, synthesis and biological evaluation of 4-(4-aminophenoxy)picolinamide derivatives as potential antitumor agents. European Journal of Medicinal Chemistry. 257. 115499–115499. 9 indexed citations
10.
Wang, Linxiao, et al.. (2023). In silico screening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL. Journal of Biomolecular Structure and Dynamics. 42(15). 7686–7698. 5 indexed citations
11.
12.
Tang, Sheng, Wenhui Gan, Linxiao Wang, et al.. (2023). Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)-7-methoxyquinazoline derivatives as dual EGFR/c-Met inhibitors for the treatment of NSCLC. European Journal of Medicinal Chemistry. 263. 115939–115939. 11 indexed citations
13.
Wang, Linxiao, Xiuhua Wu, Jiangang Xie, et al.. (2023). ADAR1 regulates macrophage polarization and is protective against liver ischemia and reperfusion injury. Immunobiology. 229(1). 152777–152777. 3 indexed citations
14.
15.
Wang, Linxiao, Qian Zhang, Zhe Wang, Wufu Zhu, & Ning‐Hua Tan. (2021). Design, synthesis, docking, molecular dynamics and bioevaluation studies on novel N-methylpicolinamide and thienopyrimidine derivatives with inhibiting NF-κB and TAK1 activities: Cheminformatics tools RDKit applied in drug design. European Journal of Medicinal Chemistry. 223. 113576–113576. 18 indexed citations
16.
Zhang, Qing, Jing Wang, Liang Zhu, et al.. (2021). Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats. Current Medical Science. 41(3). 548–554. 22 indexed citations
17.
Zhang, Chengliang, et al.. (2019). Restraint devices for repetitive transcranial magnetic stimulation in mice and rats. Brain and Behavior. 9(6). e01305–e01305. 18 indexed citations
19.
Wang, Linxiao, Yanyan Liu, Guoying Dong, et al.. (2017). The role of S‐nitrosylation of kainate‐type of ionotropic glutamate receptor 2 in epilepsy induced by kainic acid. Journal of Neurochemistry. 144(3). 255–270. 8 indexed citations
20.
Dong, Yinfeng, Linxiao Wang, Xu‐Feng Huang, et al.. (2013). Kir6.1 Knockdown Aggravates Cerebral Ischemia/Reperfusion-Induced Neural Injury in Mice. CNS Neuroscience & Therapeutics. 19(8). 617–624. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026